Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tonix Pharmaceuticals Holding Corp. - Common Stock
(NQ:
TNXP
)
16.10
+0.46 (+2.94%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Tonix Pharmaceuticals Holding Corp. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Tonix Pharmaceuticals Stock Jumps Into Retail Spotlight After $25M Buyback Boost — Traders See ‘Blueprint For Rerating’
↗
November 18, 2025
Retail traders pointed to the expanded buyback authorization as a sign of management confidence, framing it as a potential catalyst for renewed valuation upside.
Via
Stocktwits
Why Did TNXP Stock Jump 10% Today?
↗
November 17, 2025
Tonix Pharmaceuticals on Monday announced the launch of its new drug to treat Fibromyalgia.
Via
Stocktwits
Why Tonix Pharmaceuticals (TNXP) Stock Jumped Monday Morning
↗
November 17, 2025
Tonix Pharmaceuticals shares are rising Monday morning after the company announced the U.S. commercial availability of its new drug, TONMYA.
Via
Benzinga
TONIX PHARMACEUTICALS HOLDIN (NASDAQ:TNXP) Surges 77% on Q3 Earnings Beat and Key Drug Launch
↗
November 10, 2025
Tonix Pharmaceuticals stock surged 77% after Q3 earnings beat estimates and confirming the November launch of its new fibromyalgia drug, Tonmya.
Via
Chartmill
Topics
Earnings
Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern
November 10, 2025
San Diego, CA – November 10, 2025 – Eledon Pharmaceuticals (NASDAQ: ELDN) witnessed a dramatic collapse in its stock price, shedding nearly 50% of its value following the announcement of mixed results...
Via
MarketMinute
This Pharma Stock Shot Up 4% Pre-Market After FDA Approval For Drug, Retail’s Super Bullish But Believes ‘This Is A Marathon, Not A Sprint’
↗
August 18, 2025
Via
Stocktwits
Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
August 19, 2025
Via
Benzinga
What's going on in today's session
↗
August 18, 2025
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August
↗
August 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
August 18, 2025
Via
Benzinga
Tonix Pharma Scores Best Day Since March On Hopes For First New Fibromyalgia Drug Approval in 16 Years; Retail’s Optimistic
↗
August 12, 2025
Via
Stocktwits
Monday's session: top gainers and losers
↗
August 18, 2025
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
August 18, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years
↗
August 18, 2025
FDA approves Tonmya, a non-opioid fibromyalgia therapy from Tonix, with strong trial data and U.S. launch expected in late 2025.
Via
Benzinga
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
↗
August 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
August 15, 2025
Via
Benzinga
Wondering what's happening in today's after-hours session?
↗
August 15, 2025
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
↗
August 15, 2025
Via
Benzinga
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
↗
August 14, 2025
Shares of Tonix Pharmaceuticals have rallied 30% over the past five sessions. Investors are anticipating a key catalyst for the company.
Via
Benzinga
Why Tonix Pharmaceuticals (TNXP) Stock Is Climbing This Week
↗
August 13, 2025
Shares of Tonix Pharmaceuticals are building on recent gains. The stock is trading higher as investor focus intensifies on a key, upcoming catalyst.
Via
Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
August 12, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Mercury Systems Posts Better-Than-Expected Earnings, Joins Green Dot, Arcturus Therapeutics And Other Big Stocks Moving Higher On Tuesday
↗
August 12, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 12, 2025
Via
Benzinga
Tonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA Catalyst
↗
August 12, 2025
Shares of Tonix Pharmaceuticals are trading sharply higher Tuesday morning. The stock is gaining following the release of the company's Q2 financial results and operational update.
Via
Benzinga
Topics
Earnings
Tonix Pharmaceuticals (TNXP) Files To Raise $500 Million, Shares Tumble
↗
June 12, 2025
Tonix Pharmaceuticals has filed a registration statement to sell up to $500 million in securities. The company's lead drug candidate is for the management of fibromyalgia pain.
Via
Benzinga
Oxford Industries, GameStop, Boeing And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
June 12, 2025
Via
Benzinga
Wondering what's happening in today's pre-market session?
↗
June 12, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 12, 2025
Via
Benzinga
Tonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not Pessimistic
↗
June 12, 2025
The proceeds from the purchase agreement are expected to be used for working capital and general corporate purposes.
Via
Stocktwits
Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
↗
June 12, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.